Newsroom

Press Release

NeoGenomics Schedules its Second Quarter 2021 Earnings Release for August 6, 2021

NeoGenomics Completes Inivata Acquisition - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform

NeoGenomics To Participate Virtually In Multiple Upcoming Institutional Investor Conferences

NeoGenomics To Participate In The Bank of America 2021 Health Care Conference

NeoGenomics Reports 9% Revenue Growth to $116 Million in the First Quarter

NeoGenomics to Acquire Inivata - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform

NeoGenomics Announces the Launch of Biomarker Assist KRAS Single Gene Testing (SGT) Program for Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer Patients

NeoGenomics to Participate in the 20th Annual Needham Virtual Healthcare Conference

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients